?

Colleran David

EVP, General Counsel, Corp Sec
Anika Therapeutics, Inc.
US, Bedford [HQ]
CIK 1646558

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
13,007
Price per Share :
$16.19
Equivalence :
$210,583.33

Transaction History

  • 13,007 Shares After Transaction
    Value : $n/a
    $0.0
    03/04/23
  • Footnotes:
    #1 Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 4, 2020.
    #2 Includes 640 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 13, 2022.
    #3 Reflects an aggregate of 734 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 4, 2023.
    #4 Reflects the closing price of ANIK common stock on March 3, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
  • 12,273 Shares After Transaction
    Value : $387,704.07
    $23,187.06
    03/04/23
  • 24,804 Shares After Transaction
    Value : $n/a
    $0.0
    03/11/24
  • 23,723 Shares After Transaction
    Value : $603,038.66
    $27,479.02
    03/11/24
  • 29,188 Shares After Transaction
    Value : $n/a
    $0.0
    03/11/24

Get PRO Today.

PRO unlocks 7 more insider transactions made by Colleran David